Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance

References

• Blanchard C, Barnett P, Perlmutter J, Dunman PM. Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors. Antimicrob Agents Chemother. 2014;03535–14.
   Web of Science ®Google Scholar
• Zahedi Bialvaei A, Samadi Kafil H, Ebrahimzadeh Leylabadlo H, Asgharzadeh M, Aghazadeh M. Dissemination of carbapenemases producing Gram negative bacteria in the Middle East. Iran J Microbiol. 2015;7(5):226–246.26719779
   PubMedGoogle Scholar
• Mullié C, Bouharkat B, Guiheneuf R, Serra C, Touil-Meddah AT, Sonnet P. Efflux pumps in Acinetobacter baumannii: role in antibiotic resistance and interest of efflux pump inhibitors as additional therapeutic weapons In: Méndez-Vilas A, editor. Antimicrobial Research: Novel Bioknowledge and Educational Programs. Formatex Research Center; 2017.
   Google Scholar
• Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015;31(4):707–721. doi:10.1185/03007995.2015.101898925697677
   PubMed Web of Science ®Google Scholar
• Coyne S, Courvalin P, Périchon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother. 2011;55(3):947–953. doi:10.1128/AAC.01388-1021173183
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582. doi:10.1128/CMR.00058-0718625687
   PubMed Web of Science ®Google Scholar
• Eliopoulos GM, Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254–1263. doi:10.1086/52919818444865
   PubMed Web of Science ®Google Scholar
• Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010;2(3):291. doi:10.4103/0974-777X.6853820927292
   PubMedGoogle Scholar
• Shiralizadeh S, Taghizadeh S, Asgharzadeh M, et al. Urinary tract infections: raising problem in developing countries. Rev Med Microbiol. 2018;29(4):159–165.
   Web of Science ®Google Scholar
• Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis. 2010;51(1):79–84. doi:10.1086/65297520504234
   PubMed Web of Science ®Google Scholar
• Bialvaei AZ, Kafil HS, Asgharzadeh M, Yousef Memar M, Yousefi M. Current methods for the identification of carbapenemases. J Chemother. 2016;28(1):1–19. doi:10.1179/1973947815Y.000000006326256147
   PubMed Web of Science ®Google Scholar
• Katragkou A, Roilides E. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol. 2005;43(9):4916–4917. doi:10.1128/JCM.43.9.4916-4917.200516145177
   PubMed Web of Science ®Google Scholar
• Wieczorek P, Sacha P, Hauschild T, Zórawski M, Krawczyk M, Tryniszewska E. Multidrug resistant Acinetobacter baumannii–the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Multidrug resistant Acinetobacter baumannii–the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Folia Histochem Cytobiol. 2008;46(3):. doi:10.2478/v10042-008-0056-x
   Web of Science ®Google Scholar
• Vila J, Martí S, Sanchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2007;59(6):1210–1215. doi:10.1093/jac/dkl50917324960
   PubMed Web of Science ®Google Scholar
• Ribera A, Ruiz J, Jiminez de Anta MT, Vila J. Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. J Antimicrob Chemother. 2002;49(4):697–698. doi:10.1093/jac/49.4.69711909848
   PubMed Web of Science ®Google Scholar
• Piddock LJ. Multidrug-resistance efflux pumps? Not just for resistance. Nat. Rev. Microbiol. 2006;4(8):629.16845433
   PubMed Web of Science ®Google Scholar
• Sun J, Deng Z, Yan A. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem Biophys Res Commun. 2014;453(2):254–267. doi:10.1016/j.bbrc.2014.05.09024878531
   PubMed Web of Science ®Google Scholar
• Saier MH Jr, Reddy VS, Tamang DG, Västermark ÅJ. The transporter classification database. Nucleic Acids Res. 2013;42(D1):D251–D8. doi:10.1093/nar/gkt109724225317
   PubMed Web of Science ®Google Scholar
• Saier MH Jr, Paulsen IT, editors. Phylogeny of multidrug transporters. Semin Cell Dev Biol. 2001; Elsevier.
   Web of Science ®Google Scholar
• Nikaido HJ. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob. Agents Chemother. 1989;33(11):1831.2692513
   PubMed Web of Science ®Google Scholar
• Ma D, Cook D, Alberti M, Pon N, Nikaido H, Hearst JE. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol. 1993;175(19):6299–6313. doi:10.1128/jb.175.19.6299-6313.19938407802
   PubMed Web of Science ®Google Scholar
• Aires JR, Nikaido H. Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J Bacteriol. 2005;187(6):1923–1929. doi:10.1128/JB.187.6.1923-1929.200515743938
   PubMed Web of Science ®Google Scholar
• Nikaido HJ. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 1996;178(20):5853.8830678
   PubMed Web of Science ®Google Scholar
• Pumbwe L, Piddock LJV. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett. 2002;206(2):185–189. doi:10.1111/j.1574-6968.2002.tb11007.x11814661
   PubMed Web of Science ®Google Scholar
• Gill MJ, Brenwald NP, Wise R. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance inStreptococcus pneumoniae. Antimicrob Agents Chemother. 1999;43(1):187–189.9869592
   PubMed Web of Science ®Google Scholar
• Nikaido H, editor. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol. 2001; Elsevier.
   Web of Science ®Google Scholar
• Kaatz GW, SM S. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1995;39(12):2650–2655.8592996
   PubMed Web of Science ®Google Scholar
• Webber M, Piddock LJV. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother. 2003;51(1):9–11. doi:10.1093/jac/dkg05012493781
   PubMed Web of Science ®Google Scholar
• Eswaran J, Koronakis E, Higgins MK, Hughes C, Koronakis V. Three’s company: component structures bring a closer view of tripartite drug efflux pumps. Curr Opin Struct Biol. 2004;14(6):741–747. doi:10.1016/j.sbi.2004.10.00315582398
   PubMed Web of Science ®Google Scholar
• Paulsen I. Multidrug efflux pumps and resistance: regulation and evolution. Curr Opin Microbiol. 2003;6(5):446–451. doi:10.1016/j.mib.2003.08.00514572535
   PubMed Web of Science ®Google Scholar
• Wieczorek P, Sacha P, Hauschild T, Zórawski M, Krawczyk M, Tryniszewska E. Multidrug resistant Acinetobacter baumannii–the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Folia Histochem Cytobiol. 2008;46(3):257–267. doi:10.2478/v10042-008-0056-x19056528
   PubMed Web of Science ®Google Scholar
• Magnet S, Courvalin P, Lambert TJ. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother. 2001;45(12):3375–3380. doi:10.1128/AAC.45.12.3375-3380.200111709311
   PubMed Web of Science ®Google Scholar
• Vila J, Martí S, Sanchez-Céspedes JJ. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2007;59(6):1210–1215. doi:10.1093/jac/dkl50917324960
   PubMed Web of Science ®Google Scholar
• Fournier P-E, Vallenet D, Barbe V, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006;2(1):e7.16415984
   PubMed Web of Science ®Google Scholar
• Quistgaard EM, Löw C, Guettou F, Nordlund PJ. Understanding transport by the major facilitator superfamily (MFS): structures pave the way. Nat Rev Mol Cell Biol. 2016;17(2):123.26758938
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy G, Leus IV, Weeks JW, Wolloscheck D, Rybenkov VV, Zgurskaya HI. Synergy between active efflux and outer membrane diffusion defines rules of antibiotic permeation into Gram-negative bacteria. mBio. 2017;8(5):e01172–17. doi:10.1128/mBio.01172-1729089426
   PubMed Web of Science ®Google Scholar
• Zwama M, Yamasaki S, Nakashima R, Sakurai K, Nishino K, Yamaguchi AJ. Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition. Nat Commun. 2018;9(1):124.29317622
   PubMed Web of Science ®Google Scholar
• Venter H, Mowla R, Ohene-Agyei T, Ma SJ. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition. Front Microbiol. 2015;6(377).
   Google Scholar
• Li X-Z, Nikaido H. Antimicrobial drug efflux pumps in Escherichia coli In: Efflux-Mediated Antimicrobial Resistance in Bacteria. Drugs. 2009;69(12):1555–1623.19678712
   PubMedGoogle Scholar
• Li X-Z, Plésiat P, Nikaido HJ. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015;28(2):337–418. doi:10.1128/CMR.00117-1425788514
   PubMed Web of Science ®Google Scholar
• Sapunaric F, Aldema-Ramos M, McMurry L. Tetracycline Resistance: Efflux, Mutation, and Other Mechanisms. In: White D, Alekshun M, McDermott P, editors. Frontiers in Antimicrobial Resistance Washington, DC: ASM Press;2005:3–18. doi:10.1128/9781555817572.ch1.
   Google Scholar
• McMurry L, Petrucci RE, Levy SB. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc Natl Acad Sci U S A. 1980;77(7):3974–3977. doi:10.1073/pnas.77.7.39747001450
   PubMed Web of Science ®Google Scholar
• Yamaguchi A, Udagawa T, Sawai TJ. Transport of divalent cations with tetracycline as mediated by the transposon Tn10-encoded tetracycline resistance protein. J Biol Chem. 1990;265(9):4809–4813.2156856
   PubMed Web of Science ®Google Scholar
• Tamura N, Konishi S, Yamaguchi AJ. Mechanisms of drug/H+ antiport: complete cysteine-scanning mutagenesis and the protein engineering approach. Curr Opin Chem Biol. 2003;7(5):570–579. doi:10.1016/j.cbpa.2003.08.01414580560
   PubMed Web of Science ®Google Scholar
• Marger MD, Saier MH Jr. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem Sci. 1993;18(1):13–20.8438231
   PubMed Web of Science ®Google Scholar
• Lin M-F, Lin -Y-Y, Lan C-Y. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii. J Microbiol. 2017;55(2):130–136. doi:10.1007/s12275-017-6408-528120193
   PubMed Web of Science ®Google Scholar
• Marchand I, Damier-Piolle L, Courvalin P, Lambert T. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii Is regulated by the AdeRS two-component system. Antimicrob Agents Chemother. 2004;48(9):3298–3304. doi:10.1128/AAC.48.9.3298-3304.200415328088
   PubMed Web of Science ®Google Scholar
• Rajamohan G, Srinivasan VB, Gebreyes WA. Novel role of Acinetobacter baumannii RND efflux transporters in mediating decreased susceptibility to biocides. J Antimicrob Chemother. 2009;65(2):228–232. doi:10.1093/jac/dkp42720008046
   PubMed Web of Science ®Google Scholar
• Yoon E-J, Courvalin P, Grillot-Courvalin C. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother. 2013;57(7):2989–2995. doi:10.1128/AAC.02556-1223587960
   PubMed Web of Science ®Google Scholar
• Abdi SN, Ghotaslou R, Asgharzadeh M, et al. AdeB efflux pump gene knockdown by mRNA mediated peptide nucleic acid in multidrug resistance Acinetobacter baumannii. Microb Pathog. 2020;138:1.
   Google Scholar
• Radestock S, Forrest LR. The alternating-access mechanism of MFS transporters arises from inverted-topology repeats. J Mol Biol. 2011;407(5):698–715. doi:10.1016/j.jmb.2011.02.00821315728
   PubMed Web of Science ®Google Scholar
• Yan N. Structural advances for the major facilitator superfamily (MFS) transporters. Trends Biochem Sci. 2013;38(3):151–159. doi:10.1016/j.tibs.2013.01.00323403214
   PubMed Web of Science ®Google Scholar
• Reddy VS, Shlykov MA, Castillo R, Sun EI, Saier MH. The major facilitator superfamily (MFS) revisited. FEBS J. 2012;279(11):2022–2035. doi:10.1111/j.1742-4658.2012.08588.x22458847
   PubMed Web of Science ®Google Scholar
• Ehrnstorfer IA, Manatschal C, Arnold FM, Laederach J, Dutzler RJ. Structural and mechanistic basis of proton-coupled metal ion transport in the SLC11/NRAMP family. Nat Commun. 2017;8:14033.28059071
   PubMed Web of Science ®Google Scholar
• Marti S, Fernandez-Cuenca F, Pascual A, et al. Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in Acinetobacter baumannii clinical isolates. Enferm Infecc Microbiol Clin. 2006;24(2):77.16545313
   PubMed Web of Science ®Google Scholar
• Sahu PK, Iyer PS, Gaikwad MB, Talreja SC, Pardesi KR, Chopade BA. An MFS transporter-like ORF from MDR Acinetobacter baumannii AIIMS 7 is associated with adherence and biofilm formation on biotic/abiotic surface. Int J Microbiol. 2012;2012.
   Google Scholar
• Sharma A, Sharma R, Bhattacharyya T, Bhando T, Pathania R. Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter—AbaF. J Antimicrob Chemother. 2016;72(1):68–74. doi:10.1093/jac/dkw38227650185
   PubMed Web of Science ®Google Scholar
• Yerushalmi H, Lebendiker M, Schuldiner S. EmrE, an Escherichia coli 12-kDa multidrug transporter, exchanges toxic cations and H+ and is soluble in organic solvents. J Biol Chem. 1995;270(12):6856–6863. doi:10.1074/jbc.270.12.68567896833
   PubMed Web of Science ®Google Scholar
• Srinivasan VB, Rajamohan G, Gebreyes WA. Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53(12):5312–5316. doi:10.1128/AAC.00748-0919770280
   PubMed Web of Science ®Google Scholar
• Narenji H, Gholizadeh P, Aghazadeh M, Rezaee MA, Asgharzadeh M, Kafil HS. Peptide nucleic acids (PNAs): currently potential bactericidal agents. Biomed Pharmacother. 2017;93:580–588. doi:10.1016/j.biopha.2017.06.09228686972
   PubMed Web of Science ®Google Scholar
• Choudhury HG, Tong Z, Mathavan I, et al. Structure of an antibacterial peptide ATP-binding cassette transporter in a novel outward occluded state. Proc Natl Acad Sci U S A. 2014;111(25):9145–9150. doi:10.1073/pnas.132050611124920594
   PubMed Web of Science ®Google Scholar
• Verhalen B, Dastvan R, Thangapandian S, et al. Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein. Nature. 2017;543(7647):738.28289287
   PubMed Web of Science ®Google Scholar
• Hürlimann LM, Hohl M, Seeger MA. Split tasks of asymmetric nucleotide‐binding sites in the heterodimeric ABC exporter EfrCD. FEBS J. 2017;284(11):1672–1687. doi:10.1111/febs.1406528417533
   PubMed Web of Science ®Google Scholar
• Cannon RD, Lamping E, Holmes AR, et al. Efflux-mediated antifungal drug resistance. Clin Microbiol Rev. 2009;22(2):291–321.19366916
   PubMed Web of Science ®Google Scholar
• Woebking B, Reuter G, Shilling RA, et al. Drug-lipid A interactions on the Escherichia coli ABC transporter MsbA. J Bacteriol. 2005;187(18):6363–6369. doi:10.1128/JB.187.18.6363-6369.200516159769
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Nishino K, Yamaguchi A. Novel macrolide-specific ABC-type efflux transporter inEscherichia coli. J Bacteriol. 2001;183(19):5639–5644. doi:10.1128/JB.183.19.5639-5644.200111544226
   PubMed Web of Science ®Google Scholar
• Locher KP. Mechanistic diversity in ATP-binding cassette (ABC) transporters. Nat Struct Mol Biol. 2016;23(6):487. doi:10.1038/nsmb.321627273632
   PubMed Web of Science ®Google Scholar
• Okada U, Yamashita E, Neuberger A, Morimoto M, van Veen HW, Murakami S. Crystal structure of tripartite-type ABC transporter MacB from Acinetobacter baumannii. Nat Commun. 2017;8(1):1336. doi:10.1038/s41467-017-01399-229109439
   PubMed Web of Science ®Google Scholar
• Kuroda T, Tsuchiya TJ. Multidrug efflux transporters in the MATE family. Biochim Biophys Acta. 2009;1794(5):763–768. doi:10.1016/j.bbapap.2008.11.01219100867
   PubMed Web of Science ®Google Scholar
• He X, Szewczyk P, Karyakin A, et al. Structure of a cation-bound multidrug and toxic compound extrusion transporter. Nature. 2010;467(7318):991.20861838
   PubMed Web of Science ®Google Scholar
• Su X-Z, Chen J, Mizushima T, Kuroda T, Tsuchiya TJ. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob Agents Chemother. 2005;49(10):4362–4364. doi:10.1128/AAC.49.10.4362-4364.200516189122
   PubMed Web of Science ®Google Scholar
• West AH, Stock AM. Histidine kinases and response regulator proteins in two-component signaling systems. Trends Biochem Sci. 2001;26(6):369–376. doi:10.1016/s0968-0004(01)01852-711406410
   PubMed Web of Science ®Google Scholar
• Baranova N, Nikaido HJ. The baeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate. J Bacteriol. 2002;184(15):4168–4176. doi:10.1128/jb.184.15.4168-4176.200212107134
   PubMed Web of Science ®Google Scholar
• Perron K, Caille O, Rossier C, Van Delden C, Dumas J-L, Köhler TJ. CzcR-CzcS, a two-component system involved in heavy metal and carbapenem resistance in Pseudomonas aeruginosa. J Biol Chem. 2004;279(10):8761–8768. doi:10.1074/jbc.M31208020014679195
   PubMed Web of Science ®Google Scholar
• Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev. 1996;19(1):1–24. doi:10.1111/j.1574-6976.1996.tb00251.x8916553
   PubMed Web of Science ®Google Scholar
• Touzé T, Eswaran J, Bokma E, Koronakis E, Hughes C, Koronakis VJ. Interactions underlying assembly of the Escherichia coli AcrAB–TolC multidrug efflux system. Mol Microbiol. 2004;53(2):697–706. doi:10.1111/j.1365-2958.2004.04158.x15228545
   PubMed Web of Science ®Google Scholar
• Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev. 2006;19(2):382–402. doi:10.1128/CMR.19.2.382-402.200616614254
   PubMed Web of Science ®Google Scholar
• Hassan KA, Liu Q, Elbourne LDH, et al. Pacing across the membrane: the novel PACE family of efflux pumps is widespread in Gram-negative pathogens. Res Microbiol. 2018;169(7–8):450–454. doi:10.1016/j.resmic.2018.01.00129409983
   PubMed Web of Science ®Google Scholar
• Stavri M, Piddock LJ, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother. 2006;59(6):1247–1260. doi:10.1093/jac/dkl46017145734
   PubMed Web of Science ®Google Scholar
• Lorenzi V, Muselli A, Bernardini AF, et al. Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species. Antimicrob Agents Chemother. 2009;53(5):2209–2211. doi:10.1128/AAC.00919-0819258278
   PubMed Web of Science ®Google Scholar
• Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler SJ. Bacterial persistence as a phenotypic switch. Science (New York, N.Y.). 2004;305(5690):1622–1625. doi:10.1126/science.1099390
   PubMed Web of Science ®Google Scholar
• Pu Y, Zhao Z, Li Y, et al. Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol Cell. 2016;62(2):284–294.27105118
   PubMed Web of Science ®Google Scholar
• Du D, Wang-Kan X, Neuberger A, et al. Multidrug efflux pumps: structure, function and regulation. Nat Rev Microbiol. 2018;16:523–539. doi:10.1038/s41579-018-0048-630002505
   PubMed Web of Science ®Google Scholar
• Everett MJ, Jin YF, Ricci V, Piddock LJ. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother. 1996;40(10):2380–2386.8891148
   PubMed Web of Science ®Google Scholar
• Zampieri M, Enke T, Chubukov V, Ricci V, Piddock L, Sauer UJ. Metabolic constraints on the evolution of antibiotic resistance. Mol Syst Biol. 2017;13(3):917.28265005
   PubMed Web of Science ®Google Scholar
• Bailey AM, Ivens A, Kingsley R, Cottell JL, Wain J, Piddock LJV. RamA, a member of the AraC/XylS family, influences both virulence and efflux in Salmonella enterica serovar Typhimurium. J Bacteriol. 2010;192(6):1607–1616. doi:10.1128/JB.01517-0920081028
   PubMed Web of Science ®Google Scholar
• Yao H, Shen Z, Wang Y, et al. Emergence of a potent multidrug efflux pump variant that enhances campylobacter resistance to multiple antibiotics. mBio. 2016;7(5):e01543–16. doi:10.1128/mBio.01543-1627651364
   PubMed Web of Science ®Google Scholar
• Ni W, Li Y, Guan J, et al. Effects of efflux pump inhibitors on colistin resistance in multidrug-resistant Gram-negative bacteria. Antimicrob Agents Chemother. 2016;60(5):3215–3218. doi:10.1128/AAC.00248-1626953203
   PubMed Web of Science ®Google Scholar
• Aghamali M, Bialvaei AZ, Aghazadeh M, Asgharzadeh M, Kafil HS. Carbapenemase inhibitors. Rev Med Microbiol. 2017;28(3):104–113. doi:10.1097/MRM.0000000000000106
   Google Scholar
• Pagès J-M, Masi M, Barbe J. Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol Med. 2005;11(8):382–389. doi:10.1016/j.molmed.2005.06.00615996519
   PubMed Web of Science ®Google Scholar
• Yılmaz Ç, Özcengiz G. Antibiotics: pharmacokinetics, toxicity, resistance and multidrug efflux pumps. Biochem Pharmacol. 2017;133:43–62. doi:10.1016/j.bcp.2016.10.00527765485
   PubMed Web of Science ®Google Scholar
• Su X-Z, Chen J, Mizushima T, Kuroda T, Tsuchiya T. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob Agents Chemother. 2005;49(10):4362–4364. doi:10.1128/AAC.49.10.4362-4364.200516189122
   PubMed Web of Science ®Google Scholar
• Li L, Hassan KA, Brown MH, Paulsen IT. Rapid multiplexed phenotypic screening identifies drug resistance functions for three novel efflux pumps in Acinetobacter baumannii. J Antimicrob Chemother. 2016;71(5):1223–1232. doi:10.1093/jac/dkv46026832750
   PubMed Web of Science ®Google Scholar
• Roca I, Marti S, Espinal P, Martínez P, Gibert I, Vila J. CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53(9):4013–4014. doi:10.1128/AAC.00584-0919581458
   PubMed Web of Science ®Google Scholar
• Schneiders T, Findlay J, Amyes SGB. Efflux pumps in Acinetobacter baumannii In: Bergogne-Bérézin E, Friedman H, Bendinelli M, editors. Acinetobacter Biology and Pathogenesis. New York, NY: Springer US; 2008:105–127.
   Google Scholar
• Fernández-Alarcón C, Miranda CD, Singer RS, et al. Detection of the floR gene in a diversity of florfenicol resistant gram-negative bacilli from Freshwater Salmon farms in chile. Zoonoses Public Health. 2010;57(3):181–188. doi:10.1111/jvb.2010.57.issue-319538451
   PubMed Web of Science ®Google Scholar
• Rajamohan G, Srinivasan VB, Gebreyes WA. Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2010;65(9):1919–1925. doi:10.1093/jac/dkq19520573661
   PubMed Web of Science ®Google Scholar
• Hassan KA, Liu Q, Henderson PJF, Paulsen IT. Homologs of the Acinetobacter baumannii AceI transporter represent a new family of bacterial multidrug efflux systems. mBio. 2015;6(1):e01982–14. doi:10.1128/mBio.01982-1425670776
   PubMed Web of Science ®Google Scholar
• Lin M-F, Lin Y-Y, Tu C-C, Lan C-Y. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance. J Microbiol Immunol Infect. 2017;50(2):224–231. doi:10.1016/j.jmii.2015.04.00426055688
   PubMedGoogle Scholar
• Pérez-Varela M, Corral J, Aranda J, Barbé J. Functional characterization of AbaQ, a novel efflux pump mediating quinolone resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 2018;62(9):e00906–18. doi:10.1128/AAC.00906-1829941648
   PubMed Web of Science ®Google Scholar